Targeted Glucose or Glutamine Metabolic Therapy Combined With PD-1/PD-L1 Checkpoint Blockade Immunotherapy for the Treatment of Tumors - Mechanisms and Strategies

Immunotherapy, especially PD-1/PD-L1 checkpoint blockade immunotherapy, has led tumor therapy into a new era. However, the vast majority of patients do not benefit from immunotherapy. One possible reason for this lack of response is that the association between tumors, immune cells and metabolic rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Guofeng, Li, Chun, Zhang, Zhilei, Liang, Ye, Liang, Zhijuan, Chen, Yuanbin, Wang, Liping, Li, Dan, Zeng, Manqin, Shan, Wenhong, Niu, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314994/
https://www.ncbi.nlm.nih.gov/pubmed/34327138
http://dx.doi.org/10.3389/fonc.2021.697894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314994/
https://www.ncbi.nlm.nih.gov/pubmed/34327138
http://dx.doi.org/10.3389/fonc.2021.697894

Ejemplares similares